Acne Vulgaris
Welcome,         Profile    Billing    Logout  
 29 Companies   28 Products   28 Products   27 Mechanisms of Action   0 Trials   447 News 


12345678910»
  • ||||||||||  Enrollment change, Trial completion date, Trial termination:  Effects of Omega-3 Fatty Acid Supplementation in Acne Patients (clinicaltrials.gov) -  Apr 20, 2019   
    P3,  N=31, Terminated, 
    N=90 --> 31 | Trial completion date: Jan 2020 --> Mar 2019 | Recruiting --> Terminated; insufficient staff to complete recruitment
  • ||||||||||  Trial completion, Enrollment change, Trial completion date, Trial primary completion date:  Long-term Follow-up Study of Subjects Who Completed Clinical Studies 755.1100_FA, 810.1100_FA, or 1064.1100_FA (clinicaltrials.gov) -  Mar 4, 2019   
    P=N/A,  N=76, Completed, 
    N=90 --> 31 | Trial completion date: Jan 2020 --> Mar 2019 | Recruiting --> Terminated; insufficient staff to complete recruitment Recruiting --> Completed | N=165 --> 76 | Trial completion date: Dec 2018 --> May 2018 | Trial primary completion date: Dec 2018 --> May 2018
  • ||||||||||  dapsone / Generic mfg.
    Trial completion, Enrollment change:  Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris (clinicaltrials.gov) -  Mar 1, 2019   
    P4,  N=20, Completed, 
    Recruiting --> Completed | N=165 --> 76 | Trial completion date: Dec 2018 --> May 2018 | Trial primary completion date: Dec 2018 --> May 2018 Recruiting --> Completed | N=30 --> 20
  • ||||||||||  Trial completion, Enrollment change, Trial completion date, Trial primary completion date:  Potential Research Study Participant Registry (clinicaltrials.gov) -  Feb 16, 2019   
    P=N/A,  N=265, Completed, 
    N=24 --> 14 | Recruiting --> Terminated Recruiting --> Completed | N=200 --> 265 | Trial completion date: Jan 2025 --> Sep 2018 | Trial primary completion date: Jan 2025 --> Sep 2018
  • ||||||||||  ketoconazole / Generic mfg.
    Trial completion, Trial completion date, Trial primary completion date:  The Study of Efficacy and Safety of 2% Ketoconazole Cream in Thai Females With Mild Degree of Post - Adolescence Acne (clinicaltrials.gov) -  Feb 8, 2019   
    P3,  N=42, Completed, 
    Recruiting --> Completed | N=200 --> 265 | Trial completion date: Jan 2025 --> Sep 2018 | Trial primary completion date: Jan 2025 --> Sep 2018 Not yet recruiting --> Completed | Trial completion date: Dec 2017 --> Dec 2018 | Trial primary completion date: Dec 2017 --> Sep 2018
  • ||||||||||  adapalene/benzoyl peroxide / Generic mfg.
    Trial completion, Trial completion date, Trial primary completion date:  PREFECT: Pilot Study of Tolerability and Effectivity of Two Combination Topical Acne Products (clinicaltrials.gov) -  Oct 23, 2018   
    P4,  N=22, Completed, 
    Not yet recruiting --> Completed | Trial completion date: Dec 2017 --> Dec 2018 | Trial primary completion date: Dec 2017 --> Sep 2018 Active, not recruiting --> Completed | Trial completion date: Dec 2016 --> Jan 2018 | Trial primary completion date: Nov 2016 --> Feb 2017
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion, Trial completion date, Trial primary completion date, Surgery:  The Incidence and Incubation Period of False Positive Cultures in Shoulder Surgery (clinicaltrials.gov) -  Aug 16, 2018   
    P=N/A,  N=100, Completed, 
    Active, not recruiting --> Completed Enrolling by invitation --> Completed | Trial completion date: Dec 2017 --> Mar 2018 | Trial primary completion date: Jul 2017 --> Mar 2018
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion, Enrollment change:  Teledermatology and Modulation of Antibiotic Dose in Acne Vulgaris (clinicaltrials.gov) -  Jul 2, 2018   
    P=N/A,  N=4, Completed, 
    Trial completion date: Dec 2017 --> Jun 2018 Recruiting --> Completed | N=50 --> 4
  • ||||||||||  DMT210 / Dermata Therap
    Trial completion:  DMT210 Topical Gel in the Treatment of Acne Rosacea (clinicaltrials.gov) -  Apr 18, 2018   
    P2,  N=107, Completed, 
    Trial completion date: Jun 2018 --> Sep 2018 | Trial primary completion date: Mar 2018 --> Sep 2017 Active, not recruiting --> Completed
  • ||||||||||  Enrollment closed, Trial primary completion date:  A Study to Evaluate the Efficacy of ELAPR002f in Females and Males With Atrophic Acne Scars (clinicaltrials.gov) -  Feb 1, 2018   
    P=N/A,  N=30, Active, not recruiting, 
    Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Dec 2017 | Trial primary completion date: Nov 2017 --> Dec 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2017 --> Mar 2018
  • ||||||||||  berdazimer sodium (SB204) / Sato Pharma, Novan
    Trial completion, Trial primary completion date:  Pharmacokinetics of Topical SB204 in Adolescents With Acne Vulgaris (clinicaltrials.gov) -  Dec 18, 2017   
    P1,  N=18, Completed, 
    Active, not recruiting --> Completed | N=80 --> 61 Active, not recruiting --> Completed | Trial primary completion date: Jun 2017 --> Aug 2016 | Active, not recruiting --> Completed | Trial primary completion date: Jun 2017 --> Aug 2016 | Active, not recruiting --> Completed | Trial primary completion date: Jun 2017 --> Aug 2016
  • ||||||||||  berdazimer sodium (SB204) / Sato Pharma, Novan
    Trial completion:  P3 Long Term Safety Study of Once Daily SB204 in Acne (clinicaltrials.gov) -  Dec 18, 2017   
    P3,  N=605, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Jun 2017 --> Aug 2016 | Active, not recruiting --> Completed | Trial primary completion date: Jun 2017 --> Aug 2016 | Active, not recruiting --> Completed | Trial primary completion date: Jun 2017 --> Aug 2016 Active, not recruiting --> Completed
  • ||||||||||  berdazimer sodium (SB204) / Sato Pharma, Novan
    Trial completion, Trial primary completion date:  P3 Study in Acne Comparing Once Daily SB204 and Vehicle (clinicaltrials.gov) -  Dec 18, 2017   
    P3,  N=1306, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Apr 2017 --> Dec 2016 | Active, not recruiting --> Completed | Trial primary completion date: Apr 2017 --> Dec 2016 | Active, not recruiting --> Completed | Trial primary completion date: Apr 2017 --> Dec 2016
  • ||||||||||  tazarotene topical / Generic mfg.
    Enrollment closed:  Comparison Between Microneedling Daycare Procedure and Tazarotene 0.1% Gel Local Application in Acne Scarring (clinicaltrials.gov) -  Nov 27, 2017   
    P=N/A,  N=36, Active, not recruiting, 
    Active, not recruiting --> Completed | Trial primary completion date: Apr 2017 --> Dec 2016 | Active, not recruiting --> Completed | Trial primary completion date: Apr 2017 --> Dec 2016 | Active, not recruiting --> Completed | Trial primary completion date: Apr 2017 --> Dec 2016 Recruiting --> Active, not recruiting
  • ||||||||||  Enrollment change, Trial termination, Trial primary completion date:  Six Months Evaluation of Next Science Acne Creams on Facial Acne in Adult Females. (clinicaltrials.gov) -  Aug 30, 2017   
    P,  N=2, Terminated, 
    Recruiting --> Completed | N=60 --> 85 N=25 --> 2 | Recruiting --> Terminated | Trial primary completion date: Dec 2017 --> Aug 2017; Decision from the Sponsor
  • ||||||||||  tazarotene topical / Generic mfg.
    Trial completion:  A Study Comparing Tazarotene Cream 0.1% to TAZORAC (clinicaltrials.gov) -  Aug 9, 2017   
    P3,  N=1110, Completed, 
    Trial primary completion date: Jun 2014 --> Sep 2014 Active, not recruiting --> Completed
  • ||||||||||  benzoyl peroxide/tretinoin (IDP-120) / Bausch Health
    Trial completion:  Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris (clinicaltrials.gov) -  Jul 25, 2017   
    P2,  N=364, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Nov 2016 --> Jun 2016 Active, not recruiting --> Completed
  • ||||||||||  finasteride / Generic mfg.
    Trial completion, Enrollment change:  Finasteride Treatment of Severe Nodulocystic Acne (clinicaltrials.gov) -  Jul 21, 2017   
    P2,  N=106, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | N=180 --> 106
  • ||||||||||  DMT210 / Dermata Therap
    Enrollment closed:  DMT210 Topical Gel in the Treatment of Acne Rosacea (clinicaltrials.gov) -  Jun 8, 2017   
    P2,  N=104, Active, not recruiting, 
    Active, not recruiting --> Completed Recruiting --> Active, not recruiting
  • ||||||||||  Trial completion:  Efficacy Study in Patients With Acne Vulgaris. (clinicaltrials.gov) -  May 3, 2017   
    P2,  N=300, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed
  • ||||||||||  Erbitux (cetuximab) / Eli Lilly
    Trial completion, Trial primary completion date:  Does Acne Rash During Adolescence Predict Skin Reaction to Cetuximab (clinicaltrials.gov) -  Apr 27, 2017   
    P=N/A,  N=100, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Mar 2016 --> Apr 2017